AstraZeneca PLC (AZN)
NYSE: AZN · Real-Time Price · USD
184.07
+0.47 (0.26%)
At close: Mar 23, 2026, 4:00 PM EDT
184.06
-0.01 (-0.01%)
After-hours: Mar 23, 2026, 6:03 PM EDT

AstraZeneca Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
570,965285,150203,184208,807210,153180,505
Market Cap Growth
137.66%40.34%-2.69%-0.64%16.43%37.54%
Enterprise Value
595,724308,701227,571231,196232,752204,655
Last Close Price
184.0791.9365.5267.3567.8058.25
PE Ratio
55.9228.1129.1235.3564.271456.25
PS Ratio
9.734.853.764.564.744.82
PB Ratio
11.745.864.985.335.674.60
P/TBV Ratio
11.825.905.025.385.714.23
P/FCF Ratio
48.6024.2420.4523.2424.1137.05
P/OCF Ratio
39.2319.5617.1320.1821.4330.27
EV/Sales Ratio
10.145.264.215.055.255.47
EV/EBITDA Ratio
30.9015.8513.6317.0225.2026.98
EV/EBIT Ratio
41.6822.4622.7528.2261.95193.80
EV/FCF Ratio
50.6426.2422.9025.7326.7042.01
Debt / Equity Ratio
0.300.300.370.720.780.78
Debt / EBITDA Ratio
1.321.521.822.113.174.06
Debt / FCF Ratio
2.522.523.053.193.356.32
Net Debt / Equity Ratio
0.490.490.600.580.620.62
Net Debt / EBITDA Ratio
1.061.231.481.672.473.21
Net Debt / FCF Ratio
2.032.032.482.522.625.01
Asset Turnover
0.540.540.530.460.440.43
Inventory Turnover
3.061.801.911.631.811.91
Quick Ratio
0.680.680.670.590.640.71
Current Ratio
0.940.940.930.820.861.16
Return on Equity (ROE)
22.84%11.42%11.65%15.64%17.25%0.42%
Return on Assets (ROA)
11.21%10.40%7.90%7.16%4.90%-0.53%
Return on Invested Capital (ROIC)
15.39%14.27%10.90%9.84%6.55%-0.75%
Return on Capital Employed (ROCE)
20.95%17.22%13.63%11.64%4.91%1.63%
Earnings Yield
1.79%3.56%3.43%2.83%1.56%0.07%
FCF Yield
2.06%4.13%4.89%4.30%4.15%2.70%
Dividend Yield
1.74%1.70%2.27%2.16%2.14%2.35%
Payout Ratio
48.93%47.51%65.57%75.57%136.59%3468.75%
Buyback Yield / Dilution
-0.01%-0.01%0.24%0.02%-0.01%-0.02%
Total Shareholder Return
1.72%1.69%2.51%2.18%2.13%2.34%
Updated Feb 10, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q